Proteomics strategies for protein identification  by Resing, Katheryn A. & Ahn, Natalie G.
FEBS 29137 FEBS Letters 579 (2005) 885–889Minireview
Proteomics strategies for protein identiﬁcation
Katheryn A. Resing, Natalie G. Ahn*
Department of Chemistry and Biochemistry, Howard Hughes Medical Institute, University of Colorado, Boulder, CO 80309-0215, USA
Received 3 December 2004; revised 3 December 2004; accepted 3 December 2004
Available online 10 December 2004
Edited by Gunnar von Heijne and Anders LiljasAbstract The information from genome sequencing provides
new approaches for systems-wide understanding of protein net-
works and cellular function. DNA microarray technologies have
advanced to the point where nearly complete monitoring of gene
expression is feasible in several organisms. An equally important
goal is to comprehensive survey cellular proteomes and proﬁle
protein changes under diﬀerent cellular states. This presents a
complex analytical problem, due to the chemical variability be-
tween proteins and peptides. Here, we discuss strategies to im-
prove accuracy and sensitivity of peptide identiﬁcation,
distinguish represented protein isoforms, and quantify relative
changes in protein abundance.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The goal of proﬁling proteins and peptides represents a com-
plex analytical problem, due to high chemical variability and
solubility diﬀerences between analytes. Two strategies are
top-down proteomics, which analyzes intact proteins, and bot-
tom-up proteomics, which analyzes peptides in proteolytic di-
gests. An established top-down strategy for protein proﬁling is
two-dimensional gel electrophoresis (2DE), which displays
changes in protein expression and covalent modiﬁcation based
on protein staining intensity and electrophoretic mobility. To
identify proteins of interest, gel pieces are excised, peptides
are extracted by in-gel digestion, then analyzed by mass spec-
trometry [1]. Computer algorithms identify proteins based on
peptide mass and fragmentation (MS/MS) information to
search protein databases. Several outstanding papers have
been published using this methodology to identify novel func-
tions for deﬁned molecules [2–5]. However, 2DE can be limited
by detection sensitivity and protein solubility; high abundance
proteins generally less than 120 kDa are favored, and integral
membrane or basic proteins may be diﬃcult to resolve. Cur-
rently, no laboratory has surveyed more than several hundred
proteins by 2DE in mammalian cells [6,7], which represents
less than 10% of the probable size of a proteome, i.e., the num-
ber of expressed ORFs in a given cell type.*Corresponding author. Fax: +1 303 492 2439.
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doi:10.1016/j.febslet.2004.12.001More recently, top-down proﬁling has been carried out using
mass spectrometry by full mass analysis of proteins after frac-
tionation using partially selective adsorption matrices (e.g.,
SELDI), or by multidimensional chromatography, capillary
electrophoresis, or free ﬂow electrophoresis to resolve proteins
before mass analysis [8–10]. Because proteins are diﬃcult to
ionize, detection is limited and identiﬁcation requires mass
spectrometers capable of high resolution (e.g., 1 ppm) with
the ability to fragment large analytes. Successful results have
been obtained by top-down FT-ICR MS [11–13] although its
routine use for surveying complex samples requires further
instrument development.
A protein proﬁling strategy, variously referred to as ‘‘bottom
up’’ shotgun proteomics, multidimensional LC/MS/MS, or
multidimensional protein identiﬁcation technology (MudPIT),
involves solution proteolysis of a complex mixture of proteins,
followed by chromatographic separation of peptides prior to
MS/MS sequencing (Fig. 1) [13,14]. Often, protein separation
and enrichment is carried out before digestion, for example
by protein chromatography or organelle puriﬁcation. A varia-
tion of this approach separates proteins by SDS–PAGE, fol-
lowed by in-gel digestion of proteins which comigrate in gel
slices within narrow mass ranges, and subsequent multidimen-
sional LC/MS/MS [15]. Improved software in current mass
spectrometers allows peptide sequencing by data-dependent
data acquisition, in which ions are automatically selected
and fragmented by MS/MS, enabling thousands of spectra to
be collected in a single reversed phase analysis [16–18].
The viability of shotgun proteomics for global protein proﬁl-
ing was ﬁrst shown in a study identifying more than 1400 pro-
teins from Saccharomyces cerevisiae, including low abundance
proteins [18]. Recent studies have identiﬁed 1504 (25% of
ORFs) from S. cerevisiae, 1910 proteins in Deinococcus radio-
durans (61% of ORFs), 2415 proteins in Plasmodium falcipa-
rum (46% of ORFs), and 5130 proteins (15% of ORFs) in
human erythroleukemia cells [19–22]. In addition, large pro-
jects have been initiated to comprehensively catalog the pro-
tein content of human tissues and ﬂuids [23,24].
Protein proﬁling in higher eukaryotes presents a more com-
plex analytical problem than yeast or bacteria, due to greater
genome sizes and numbers of proteins speciﬁed, longer protein
sequences, wider protein concentration ranges, and greater
variability in alternative splice and covalently modiﬁed forms.
Mammalian protein proﬁling must address several problems in
order to improve (i) accuracy and sensitivity of peptide identi-
ﬁcation, (ii) discrimination between protein isoforms, (iii) pro-
tein quantitation, and (iv) analysis of covalent modiﬁcations.
All are consequences of the larger genome sizes of mammalianblished by Elsevier B.V. All rights reserved.
Fig. 1. Protein proﬁling by shotgun proteomics. Complex mixtures of proteins are proteolyzed in solution, and resulting peptides are simpliﬁed by
chromatographic separation prior to MS/MS sequencing. Often, protein separation and enrichment is carried out before digestion, for example by
protein chromatography, SDS–PAGE, or organelle puriﬁcation.
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Here, we discuss approaches to improve accuracy and sensitiv-
ity of peptide identiﬁcation, distinguish represented protein
isoforms, and quantify relative changes in protein abundance.2. Accuracy and sensitivity in search programs
To identify peptide sequences from MS/MS spectra, the
most successful search programs (e.g., Mascot, Sequest [25–
28]) compare observed fragment ions against theoretical ion
mass, and/or determine the statistical likelihood of generating
observed fragment ions from candidate peptide sequences rep-
resented in a protein database. A scoring method is then used
to rank the various peptide candidates, based on similarity be-
tween theoretical and observed spectra. A common approach
for validating peptide matches is to accept all assignments with
scores above a certain threshold. Thresholds for high conﬁ-
dence acceptances may be determined by searching the same
datasets against a ‘‘randomized’’ protein database, created
by inverting each protein sequence contained in the normal
database [29,30]. Each assignment is therefore incorrect, pro-
viding an estimate of false positives; from this data, threshold
values can be set which maintain false positives below a desired
level.Fig. 2 shows a histogram of scores from human peptide se-
quences. Scores obtained by searching a normal human pro-
tein database show a biphasic distribution, with the majority
of spectra with scores between 1 and 2.5, and a shoulder at
high scores representing high conﬁdence assignments. The
score distribution of incorrect assignments obtained by search-
ing a randomized database can be seen to coincide with the
major peak of normal assignments. From this analysis, scores
above XCorr = 2.55, 3.39, or 3.78, respectively, for MH1+,
MH2þ2 , or MH
3þ
3 ions produce false positives <0.5%. However,
when the distribution of correctly assigned spectra is estimated
using data collected with protein standards, more than half of
the correct assignments receive low scores and are rejected [22].
High false negatives limit the sensitivity of peptide detection,
which is related to how many spectra can be assigned accu-
rately to peptide sequences. Typically, useful peptide informa-
tion is obtained from only 8% to 25% of the data collected. For
example, extensive analyses to classify MS/MS spectra in a hu-
man dataset showed that Sequest or Mascot searches identiﬁed
24% of the spectra. Of the remaining 76%, two-thirds were
products of non-speciﬁc proteolysis, fragment ions, weak or
incorrectly formed data ﬁles, and modiﬁed peptide artifacts,
which provide little protein identiﬁcation information. The
remaining MS/MS spectra were identiﬁable and of good qual-
ity, but could not be unequivocally validated by the scoring
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Fig. 2. XCorr distribution for MH2þ2 peptides in a shotgun proteomics
dataset of 10000 MS/MS spectra human proteins. MS/MS data ﬁles
were searched against a normal human protein database using the
Sequest program (squares). Searching MS/MS spectra against a
database of randomized sequences provides a score distribution of
false positive assignments (triangles). From this distribution, threshold
values can be set which maintain false positives below a desired level,
so that peptide sequence assignments are almost always correct.
However, the distribution of MS/MS spectra with correct sequence
assignments conﬁrmed by manual analysis (circles) show that approx-
imately equal numbers of correctly assigned spectra typically score
above and below threshold. Spectra for correct sequences scoring
below threshold may be misassigned when incorrect sequences in the
database yield higher scores.
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high thresholds to minimize false positives leads to increased
numbers of false negatives. Additional strategies are needed
to improve accuracy without sacriﬁcing sensitivity.3. Improving search strategies
Various approaches generate probability rankings based
on several parameters generated by search programs [29–
33]. A program implementing a linear discriminant strategy,
named Peptide Prophet, developed coeﬃcients to weight dif-
ferent Sequest scores, using Bayesian statistics to develop a
probability ranking for sequence identiﬁcations [31].
Strengths of the program are that multiple indices were
combined to improve the discrimination of assignments. A
potential weakness is that the two strongest probability
determinants (XCorr and DCN) are positively correlated in
datasets of mammalian proteins, which may introduce biases
in probability values, thus often a large fraction of correct
assignments are not validated. Another method to improve
conﬁdence of sequence assignments uses exact peptide mass
measurements to validate peptide assignments [13,20]. Deter-
mining tryptic peptide masses to an accuracy of 1 ppm re-
stricts the number of possible matches to database
sequences, and when combined with ﬁlters based on re-
versed-phase chromatography elution [34], peptides in pro-
karyotic proteins could be determined with minimum
ambiguity. Exact mass measurements may be less powerful
for mammalian systems due to greater database size and
numbers of covalent modiﬁcations, and the FT-ICR MS
instrumentation required is expensive and not widely avail-
able. Using this method, 61% of ORFs in D. radiodurans
were identiﬁed [20], with >90% of ORFs in updated data-
sets.Signiﬁcant improvements in peptide validation can be
gained by incorporating peptide chemical information into
data reduction, which current programs do not consider exten-
sively. Filters based on peptide chromatography on ion ex-
change or reversed phase HPLC have proven successful.
Hydrophobicity indices have been used to predict peptide elu-
tion on RP, by calculating retention times of individual amino
acids, either by linear regression or using a neural net machine
learning approach [34,35]. Combining these with exact mass
measurements improved the accuracy of bacterial protein iden-
tiﬁcation, illustrating how independent inputs with low dis-
crimination individually produce high discrimination in
combination. This principle is used by an algorithm, MSPlus
[22], which evaluates consensus between search programs (Se-
quest and Mascot), reducing false negatives by allowing scor-
ing thresholds to be bypassed. Filters then evaluate the
numbers of basic residues on peptides and test their consis-
tency with SCX elution behavior, together with a RankSp
parameter from Sequest. MSPlus increases data capture com-
pared to threshold strategies, while maintaining low false posi-
tive and false negative assignments and high reproducibility in
protein identiﬁcation.
Although rules based on chemistry improve identiﬁcation of
correct sequences, sensitivity is still limited when search pro-
grams produce incorrect assignments that are later rejected.
In our analyses of human datasets, 20% of spectra are of
good quality with identiﬁable peptide sequences, but receive
higher scores for incorrect sequences. Large databases increase
the frequency of misassignments. In an experiment searching
2117 spectra against either the human IPI protein database
(48000 entries) or the same database without specifying trypsin
cleavages in the search (increasing the eﬀective database size by
>10-fold), 233 correct sequence assignments were replaced by
incorrect assignments using the larger database [22]. Thus, se-
quence inaccuracy is a more serious problem for mammalian
systems than yeast or bacteria, highlighting an important ca-
veat when applying methods developed with yeast to mamma-
lian datasets. Information capture can be optimized by
minimizing the eﬀective database size, specifying trypsin, and
ignoring covalent modiﬁcations. From a restricted set of repre-
sented proteins, datasets can then be re-searched for modiﬁed
peptides and non-tryptic cleavages.
Perhaps the ideal solution for better discrimination and
accuracy in sequence identiﬁcation is to improve the prediction
of gas phase peptide fragmentation behavior. Statistical analy-
ses of MS/MS datasets have led to empirical rules for cleavages
at diﬀerent peptide bonds in ions with diﬀerent charge states.
These support a general mechanism for peptide bond cleavage
which involves transfer of a proton to a peptide bond by vibra-
tional motion, followed by formation of an oxazolone b ion
and y ion, via attack of the backbone carbonyl oxygen at the
n  1 position [36–40]. Some bonds are particularly labile
and speciﬁc chemical mechanisms have been proposed which
account for these enhanced cleavages, such as those C-terminal
to Asp/Glu and His and N-terminal to Pro [38–40]. A ‘‘mobile
proton’’ model has been proposed to explain fragmentation
behavior, in which peptides are classiﬁed as ‘‘mobile’’ when
the number of protons exceed the total number of basic resi-
dues (Arg, Lys, His), ‘‘partially mobile’’ when the number of
protons exceed the number of Arg residues but are equal to
or less than the total number of basic residues, and ‘‘non-mo-
bile’’ when the number of protons is equal to or less than the
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Fig. 3. Relative changes in proteins quantiﬁed by stable isotope
labeling. Proteins from diﬀerent samples are diﬀerentially tagged with
isotopically labeled moieties, which include amino acids incorporated
by metabolic labeling, or chemical adducts coupled covalently follow-
ing cell disruption. Diﬀerentially labeled proteins are mixed and
proteolyzed, and peptides are analyzed by mass spectrometry. Relative
changes in protein abundance are reﬂected by ratios of peak intensity
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ated with Arg residues, precluding their migration to other res-
idues). Thus, cleavage C-terminal to Asp/Glu/His/Arg/Lys is
favored by the ability of these side chains to donate a proton,
yielding MS/MS spectra with few fragment ions and strong
bias towards these residues. Enhanced cleavage N-terminal
to Pro is explained by the greater basicity of the Pro secondary
amine, facilitating proton acceptance during cleavage.
Recently, a kinetic model based on classical kinetics and the
mobile proton hypothesis was developed to quantitatively sim-
ulate peptide MS/MS fragmentation generated in a 3D ion
trap mass spectrometer [41]. This developed a mathematical
expression describing rate constants of peptide bond fragmen-
tation based on intrinsic rates determined by adjacent amino
acids and proton aﬃnities, and also included other reactions,
e.g., dehydration, deammoniation, C-terminal rearrangements,
and loss of CO. A training set of 3D ion trap MS/MS spectra
was used to ﬁt 400 parameters deﬁning these rate constants.
Simulations using the optimized parameter set agreed well with
observed spectra for MH1+ and MH2þ2 ions up to 2000 Da. A
similarity score for overlap between theoretical and observed
spectra provided signiﬁcantly better discrimination than
XCorr or Mowse. Thus, modeling gas phase fragmentation
based on simple chemical principles greatly improved accuracy
and should improve sensitivity of protein detection by increas-
ing usable data that can be extracted.for matched isotopically labeled peptides.4. Protein isoform redundancy
An important consideration when identifying proteins
from shotgun proteomics datasets is distinguishing protein
isoforms. Ambiguity ensues when a given peptide sequence
is found in more than one protein entry, a common occur-
rence. Diﬀerent protein entries may be assigned variably to
spectra representing the same peptide sequence, which has
the eﬀect of inﬂating the protein counts and/or failing to
represent protein forms that are present in favor of another
containing the same sequence. Programs such as DTAselect
and Protein Prophet [32,42] resolve many of these ambigui-
ties, although mass neutral mutations may be overlooked.
The program, Isoform Resolver, uses an alternative peptide
centric database strategy in which the primary key is each
unique peptide sequence, and all proteins associated with
each sequence are secondary entries [22]. Improved accuracy
of protein identiﬁcations from peptide sequences is obtained
by carrying forward only the peptide sequence from the
search results, and considering all possible mass neutral
replacements as possible alternatives for the assignment.
Proteins are reconstructed by choosing peptide alternatives
in a way that minimizes protein counts. In one analysis,
minimizing protein counts that account for the observed
peptides led to a 24% reduction from the number of pro-
teins identiﬁed by Sequest or Mascot.5. Protein quantitation
Quantifying changes in protein abundance between samples
is a key goal of shotgun proteomics. Current methods are
based on isotope or mass tag labeling of peptides (Fig. 3), in
which diﬀerent samples to be compared are covalently labeledwith stable isotope-labeled moieties (e.g., 12C vs. 13C-ICAT re-
agents, methylisothiourea, 16O vs. 18O-labeled water), or met-
abolically labeled with isotopically distinguishable amino acids
(e.g., 12C vs. 13C-Arg or Lys) [17,43–46]. Proteins from each
sample are mixed and relative quantiﬁcation is determined
from the ratio of intensities between the diﬀerential isotopi-
cally labeled peaks. Shotgun proteomics coupled with peptide
quantitation by isotope labeling has been used successfully in
many applications to reveal proteomic changes in response
to signaling and cell regulation. For example, of 528 proteins
surveyed in rat ﬁbroblasts, one-third showed >2-fold changes
in protein abundance in response to c-myc signaling, including
many with regulatory functions in cell metabolism, adhesion,
and morphology [47]. However, such methods are still some-
what limited by relatively low sensitivity in mammalian sys-
tems [46]. For example, most of the proteins detected by
chemical or metabolic isotope labeling methods in recent pub-
lications are relatively abundant, numbering in the hundreds of
proteins. Obstacles in chemical labeling methods that require
further reﬁnement are unexpected chemistries as well as Km ef-
fects where low abundance peptides do not react to completion
or are poorly recovered after aﬃnity enrichment. Metabolic
labeling reduces these problems, but cannot be applied to
non-cultured cells, such as clinical tissue or serum samples.
Both approaches have problems in resolving isotope peaks
for larger peptides and require identiﬁcation of both labeled
forms of a peptide.
Promising alternative methods for quantitation involve la-
bel-free approaches. Measurement of peptide ion intensities
from LC/MS proﬁles is often used in drug metabolism studies
and to estimate stoichiometry of covalently modiﬁed peptides.
Recently, the feasibility of quantitation from direct measure-
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dard curves of proteins added to serum samples [48,49]. Statis-
tical modeling of peak intensities demonstrated good
correlations between relative peak intensities of peptide ions
and relative protein abundances. A second method counts
the total number of MS/MS spectra of peptides in a protein
(spectral counts), which was shown to be linearly related to
protein abundance in tests of standard proteins added to yeast
extracts [50]. With controls for normalization between runs, la-
bel-free quantitation may oﬀer a simpler approach for analysis.
Spectral sampling should also enable ranking of diﬀerent pro-
teins by their relative abundances, providing information that
other methods cannot achieve.References
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